Plaque Psoriasis Oral Medication Study (52 Weeks)

Adults 18-80 years of age with chronic plaque psoriasis for at least 6 months, may qualify to participate. Eligible participants must have plaque psoriasis covering at least 10% of their body, with moderate to severe disease at the time of study entry.

Participants will receive investigational oral medication (active drug), an active comparator or placebo. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 52 weeks and include about 14 visits to the study centre, plus 1 phone visit.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more